دورية أكاديمية
MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation.
العنوان: | MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation. |
---|---|
المؤلفون: | Sheikh TI; Molecular Neuropsychiatry & Development (MiND) Lab, Brain Science Division, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada., de Paz AM; Department of Biochemistry and Microbiology, University of Victoria, BC V8P 5C2, Canada., Akhtar S; University of Engineering and Technology Taxila, Taxila, Punjab 47080, Pakistan., Ausió J; Department of Biochemistry and Microbiology, University of Victoria, BC V8P 5C2, Canada., Vincent JB; Molecular Neuropsychiatry & Development (MiND) Lab, Brain Science Division, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. |
المصدر: | Human molecular genetics [Hum Mol Genet] 2017 Nov 01; Vol. 26 (21), pp. 4132-4141. |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9208958 Publication Model: Print Cited Medium: Internet ISSN: 1460-2083 (Electronic) Linking ISSN: 09646906 NLM ISO Abbreviation: Hum Mol Genet Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Oxford, England ; New York : IRL Press at Oxford University Press, c1992- |
مواضيع طبية MeSH: | Methyl-CpG-Binding Protein 2/*genetics , Methyl-CpG-Binding Protein 2/*metabolism, Alternative Splicing ; Amino Acid Sequence ; Animals ; Cell Line ; Exons ; HEK293 Cells ; Humans ; Mice ; Mutation ; Mutation, Missense ; Protein Isoforms ; Protein Processing, Post-Translational ; Proteolysis ; RNA, Messenger/genetics ; Rett Syndrome/genetics ; Signal Transduction |
مستخلص: | Methyl CpG-binding protein 2 (MeCP2), the mutated protein in Rett syndrome (RTT), is a crucial chromatin-modifying and gene-regulatory protein that has two main isoforms (MeCP2_E1 and MeCP2_ E2) due to the alternative splicing and switching between translation start codons in exons one and two. Functionally, these two isoforms appear to be virtually identical; however, evidence suggests that only MeCP2_E1 is relevant to RTT, including a single RTT missense mutation in exon 1, Ala2Val. Here, we show that N-terminal co- and post-translational modifications differ for MeCP2_E1 and MeCP2_E1-Ala2Val, which result in different protein degradation rates in vitro. We report complete N-methionine excision (NME) for MeCP2_E1 and evidence of excision of multiple alanine residues from the N-terminal polyalanine stretch. For MeCP2_E1-Ala2Val, we observed only partial NME and N-acetylation (NA) of either methionine or valine. The localization of MeCP2_E1 and co-localization with chromatin appear to be unaffected by the Ala2Val mutation. However, a higher proteasomal degradation rate was observed for MeCP2_E1-Ala2Val compared with that for wild type MeCP2_E1. Thus, the etiopathology of Ala2Val is likely due to a reduced bio-availability of MeCP2 because of the faster degradation rate of the unmodified defective protein. Our data on the effects of the Ala2Val mutation on N-terminal modifications of MeCP2 may be applicable to Ala2Val mutations in other disease genes for which no etiopathological mechanism has been established. (© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.) |
References: | J Biol Chem. 2012 Apr 20;287(17):13859-67. (PMID: 22375006) Nat Cell Biol. 2004 May;6(5):379-80. (PMID: 15122260) Eur J Hum Genet. 2012 Jan;20(1):69-76. (PMID: 21829232) Nucleic Acids Res. 2004 Mar 19;32(5):1818-23. (PMID: 15034150) Proteomics. 2015 Jul;15(14):2402-9. (PMID: 25920796) Sci Rep. 2016 Dec 08;6:38590. (PMID: 27929079) J Biol Chem. 2000 Nov 24;275(47):36479-82. (PMID: 11013267) Nat Genet. 2002 Oct;32(2):285-9. (PMID: 12219090) Orphanet J Rare Dis. 2013 Jul 19;8:108. (PMID: 23866855) Hum Mol Genet. 2004 Nov 1;13(21):2679-89. (PMID: 15351775) Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):355-60. (PMID: 17171659) Trends Cell Biol. 2004 Mar;14(3):103-6. (PMID: 15055197) Cell. 1992 Jun 12;69(6):905-14. (PMID: 1606614) Mol Cell Biol. 2008 Jun;28(11):3861-72. (PMID: 18391024) J Cell Sci. 2010 Oct 1;123(Pt 19):3235-43. (PMID: 20807799) Bioinformatics. 2012 Jul 1;28(13):1800-1. (PMID: 22543368) Nat Protoc. 2012 Mar 29;7(4):801-11. (PMID: 22461069) Nat Genet. 2004 Apr;36(4):339-41. (PMID: 15034579) Hum Mutat. 2015 Feb;36(2):232-9. (PMID: 25393721) Biochem Cell Biol. 2009 Feb;87(1):219-27. (PMID: 19234536) Science. 2010 Feb 19;327(5968):973-7. (PMID: 20110468) Neurogenetics. 2009 Apr;10(2):127-33. (PMID: 19034540) Nat Genet. 1999 Oct;23(2):185-8. (PMID: 10508514) Nucleic Acids Res. 1992 Oct 11;20(19):5085-92. (PMID: 1408825) Genet Med. 2009 Apr;11(4):241-7. (PMID: 19282774) Hum Mol Genet. 2011 Nov 1;20(21):4187-95. (PMID: 21831886) Hum Mol Genet. 2014 May 1;23(9):2447-58. (PMID: 24352790) PLoS Biol. 2011 May;9(5):e1001073. (PMID: 21655302) Nat Cell Biol. 2004 May;6(5):405-13. (PMID: 15077113) Mamm Genome. 2000 Mar;11(3):182-90. (PMID: 10723722) Am J Med Genet A. 2009 May;149A(5):1019-23. (PMID: 19365833) Mol Cell Proteomics. 2006 Dec;5(12):2336-49. (PMID: 16963780) Am J Med Genet A. 2010 May;152A(5):1079-88. (PMID: 20425814) Science. 2011 Feb 11;331(6018):764-8. (PMID: 21233346) Mol Cell Proteomics. 2010 May;9(5):928-39. (PMID: 20061308) Bioessays. 1985 Jul;3(1):27-31. (PMID: 3024631) Environ Health Perspect. 2008 Mar;116(3):284-91. (PMID: 18335092) Thorax. 2001 Nov;56(11):891-4. (PMID: 11641517) Hum Mol Genet. 2000 Oct;9(16):2365-75. (PMID: 11005791) Lancet. 2004 Jan 31;363(9406):371-2. (PMID: 15070570) PLoS Biol. 2005 Mar;3(3):e67. (PMID: 15737020) Biochemistry. 2010 Jul 6;49(26):5588-99. (PMID: 20521764) J Comp Neurol. 2007 Apr 1;501(4):526-42. (PMID: 17278130) Anal Biochem. 1999 Apr 10;269(1):105-12. (PMID: 10094780) Genetics. 2005 Aug;170(4):1553-60. (PMID: 15911569) Exp Cell Biol. 1986;54(5-6):287-300. (PMID: 3026862) |
معلومات مُعتمدة: | MOP -130417 Canada CIHR |
المشرفين على المادة: | 0 (MECP2 protein, human) 0 (Mecp2 protein, mouse) 0 (Methyl-CpG-Binding Protein 2) 0 (Protein Isoforms) 0 (RNA, Messenger) |
تواريخ الأحداث: | Date Created: 20171004 Date Completed: 20180321 Latest Revision: 20181113 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC5886153 |
DOI: | 10.1093/hmg/ddx300 |
PMID: | 28973632 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1460-2083 |
---|---|
DOI: | 10.1093/hmg/ddx300 |